Aashka Shah
Endocrinology physician
Also affiliated: Twitter (United States) (2023); Siddhartha Medical College (2023); Tufts University (2023); Tufts Medical Center (2020–2023); Carle Foundation Hospital (2023); Xinjiang Medical University (2023); University of Illinois Urbana-Champaign (2023); Illinois College (2023); Virginia Commonwealth University (2023–2025); Wayne State University (2012–2016); University of Arkansas Medical Center (2021–2022); Detroit Medical Center (2012); Tufts Children's Hospital (2020–2023); Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College (2023); ACS Medical College and Hospital (2024); Central Arkansas Veterans Healthcare System (2021–2022); Queens Hospital Center (2023); Mount Sinai Hospital (2023); Children's Hospital 2 (2023); Pramukhswami Medical College (2023–2025); University of Applied Management Studies (2022); North Coast Marine Mammal Center (2018); Saint Michael's Medical Center (2020); Smt. N.H.L. Municipal Medical College (2023); Cook County Health and Hospitals System (2023); Narendra Modi Medical College (2020); B.J. Medical College (2020); Karnataka Institute of Medical Sciences (2023)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Aashka Shah's research focuses on injury epidemiology and prevention, with a particular emphasis on venous thromboembolism in pediatric trauma patients. She has contributed to multicenter analyses investigating risk stratification and the impact of institutional prophylaxis guidelines on venous thromboembolism rates following trauma. Her work also extends to understanding risk factors and reduction strategies for Sudden Infant Death Syndrome.
Shah has also investigated rare medical cases, including isolated traumatic gallbladder injury and cysticercosis of the eyelid. Her scholarship includes work on the discontinuation of levothyroxine therapy for subclinical hypothyroidism and the prevalence of Glucose 6 Phosphate Dehydrogenase Deficiency. She has an h-index of 5 with 35 publications and 93 citations, and collaborates with researchers at the University of Arkansas for Medical Sciences, including Arwa Albashaireh and Sabah Syed.
Metrics
- h-index: 5
- Publications: 35
- Citations: 98
Selected Publications
-
Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial (2025)
-
THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial (2023)
-
Abstract #1158365: Osteoporosis Pseudoglioma with hypergammaglobulinemia: A rare case (2022)
-
Hypothyroid Patients Describe What Brain Fog Feels Like (2022)
-
A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid Lobectomy (2021)
-
Glucagonoma: “A Diagnostic Challenge” (2021)
Collaboration Network
Top Collaborators
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Hypothyroid Patients Describe What Brain Fog Feels Like
- A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid Lobectomy
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Glucagonoma: “A Diagnostic Challenge”
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Glucagonoma: “A Diagnostic Challenge”
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- Abstract #1158365: Osteoporosis Pseudoglioma with hypergammaglobulinemia: A rare case
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial
- THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
- Glucagonoma: “A Diagnostic Challenge”
- Glucagonoma: “A Diagnostic Challenge”
- Glucagonoma: “A Diagnostic Challenge”
Similar Researchers
Based on overlapping research topics